Sintilimab and Anlotinib Combined With Chemotherapy in Neoadjuvant Treatment of Resectable Esophageal Cancer

Condition:   Sintilimab and Anlotinib in Combination With Chemotherapy Intervention:   Drug: Sintilimab and anlotinib in combination with chemotherapy Sponsor:   Tang-Du Hospital Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials